A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans
Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) are nov...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Default Article |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/10120382.v1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|